Development of a more highly selective M1 antagonist from the continued optimization of the MLPCN Probe ML012

Autor: Melancon, Bruce J., Lamers, Alexander P., Bridges, Thomas M., Sulikowski, Gary A., Utley, Thomas J., Sheffler, Douglas J., Noetzel, Meredith J., Morrison, Ryan D., Scott Daniels, J., Niswender, Colleen M., Jones, Carrie K., Jeffrey Conn, P., Lindsley, Craig W., Wood, Michael R.
Zdroj: In Bioorganic & Medicinal Chemistry Letters 15 January 2012 22(2):1044-1048
Databáze: ScienceDirect